RT induces immunogenic cancer cell death, which results in calreticulin (CRT) exposure on the cells surface and the release of tumor neoantigens as well as death-associated molecular patterns (DAMPs; among others, adenosine triphosphate (ATP) and high mobility group box 1 (HMGB1) protein). The gene discussed is CALR; the disease is cancer.